Sox2 Is Required to Maintain Cancer Stem Cells in a Mouse Model of High-Grade Oligodendroglioma

被引:83
作者
Favaro, Rebecca [1 ]
Appolloni, Irene [5 ]
Pellegatta, Serena [2 ,3 ]
Sanga, Alexandra Badiola [1 ]
Pagella, Pierfrancesco [1 ]
Gambini, Eleonora [5 ]
Pisati, Federica [4 ]
Ottolenghi, Sergio [1 ]
Foti, Maria [1 ]
Finocchiaro, Gaetano [2 ]
Malatesta, Paolo [5 ]
Nicolis, Silvia K. [1 ]
机构
[1] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy
[2] Fdn IRCCS Ist Neurol C Besta, Dept Mol Neurooncol, Milan, Italy
[3] IFOM IEO Campus, European Inst Oncol, Dept Expt Oncol, Milan, Italy
[4] IFOM IEO Campus, FIRC Inst Mol Oncol Fdn IFOM, Tissue Proc Unit, Milan, Italy
[5] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Genoa, Italy
关键词
TUMOR-INITIATING CELLS; GROWTH-FACTOR; SELF-RENEWAL; PDGF; MEDULLOBLASTOMA; TUMORIGENICITY; PROLIFERATION; NEURONS; SHH; IDENTIFICATION;
D O I
10.1158/0008-5472.CAN-13-1942
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The stem cell-determining transcription factor Sox2 is required for the maintenance of normal neural stem cells. In this study, we investigated the requirement for Sox2 in neural cancer stem-like cells using a conditional genetic deletion mutant in a mouse model of platelet-derived growth factor-induced malignant oligodendroglioma. Transplanting wild-type oligodendroglioma cells into the brain generated lethal tumors, but mice transplanted with Sox2-deleted cells remained free of tumors. Loss of the tumor-initiating ability of Sox2-deleted cells was reversed by lentiviral-mediated expression of Sox2. In cell culture, Sox2-deleted tumor cells were highly sensitive to differentiation stimuli, displaying impaired proliferation, increased cell death, and aberrant differentiation. Gene expression analysis revealed an early transcriptional response to Sox2 loss. The observed requirement of oligodendroglioma stem cells for Sox2 suggested its relevance as a target for therapy. In support of this possibility, an immunotherapeutic approach based on immunization of mice with SOX2 peptides delayed tumor development and prolonged survival. Taken together, our results showed that Sox2 is essential for tumor initiation by mouse oligodendroglioma cells, and they illustrated a Sox2-directed strategy of immunotherapy to eradicate tumor-initiating cells. (C) 2014 AACR.
引用
收藏
页码:1833 / 1844
页数:12
相关论文
共 51 条
[1]   Sox2 Requirement in Sonic Hedgehog-Associated Medulloblastoma [J].
Ahlfeld, Julia ;
Favaro, Rebecca ;
Pagella, Pierfrancesco ;
Kretzschmar, Hans A. ;
Nicolis, Silvia ;
Schueller, Ulrich .
CANCER RESEARCH, 2013, 73 (12) :3796-3807
[2]   Antagonistic modulation of gliomagenesis by Pax6 and Olig2 in PDGF-induced oligodendroglioma [J].
Appolloni, Irene ;
Calzolari, Filippo ;
Barilari, Manuela ;
Terrile, Marta ;
Daga, Antonio ;
Malatesta, Paolo .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (07) :E1078-E1087
[3]   PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors [J].
Appolloni, Irene ;
Calzolari, Filippo ;
Tutucci, Evelina ;
Caviglia, Sara ;
Terrile, Marta ;
Corte, Giorgio ;
Malatesta, Paolo .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (10) :2251-2259
[4]   Sox2+ Adult Stem and Progenitor Cells Are Important for Tissue Regeneration and Survival of Mice [J].
Arnold, Katrin ;
Sarkar, Abby ;
Yram, Mary Anna ;
Polo, Jose M. ;
Bronson, Rod ;
Sengupta, Sumitra ;
Seandel, Marco ;
Geijsen, Niels ;
Hochedlinger, Konrad .
CELL STEM CELL, 2011, 9 (04) :317-329
[5]   Multipotent cell lineages in early mouse development depend on SOX2 function [J].
Avilion, AA ;
Nicolis, SK ;
Pevny, LH ;
Perez, L ;
Vivian, N ;
Lovell-Badge, R .
GENES & DEVELOPMENT, 2003, 17 (01) :126-140
[6]   SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas [J].
Bass, Adam J. ;
Watanabe, Hideo ;
Mermel, Craig H. ;
Yu, Soyoung ;
Perner, Sven ;
Verhaak, Roel G. ;
Kim, So Young ;
Wardwell, Leslie ;
Tamayo, Pablo ;
Gat-Viks, Irit ;
Ramos, Alex H. ;
Woo, Michele S. ;
Weir, Barbara A. ;
Getz, Gad ;
Beroukhim, Rameen ;
O'Kelly, Michael ;
Dutt, Amit ;
Rozenblatt-Rosen, Orit ;
Dziunycz, Piotr ;
Komisarof, Justin ;
Chirieac, Lucian R. ;
LaFargue, Christopher J. ;
Scheble, Veit ;
Wilbertz, Theresia ;
Ma, Changqing ;
Rao, Shilpa ;
Nakagawa, Hiroshi ;
Stairs, Douglas B. ;
Lin, Lin ;
Giordano, Thomas J. ;
Wagner, Patrick ;
Minna, John D. ;
Gazdar, Adi F. ;
Zhu, Chang Qi ;
Brose, Marcia S. ;
Cecconello, Ivan ;
Ribeiro, Ulysses, Jr. ;
Marie, Suely K. ;
Dahl, Olav ;
Shivdasani, Ramesh A. ;
Tsao, Ming-Sound ;
Rubin, Mark A. ;
Wong, Kwok K. ;
Regev, Aviv ;
Hahn, William C. ;
Beer, David G. ;
Rustgi, Anil K. ;
Meyerson, Matthew .
NATURE GENETICS, 2009, 41 (11) :1238-U105
[7]   Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas [J].
Basu-Roy, U. ;
Seo, E. ;
Ramanathapuram, L. ;
Rapp, T. B. ;
Perry, J. A. ;
Orkin, S. H. ;
Mansukhani, A. ;
Basilico, C. .
ONCOGENE, 2012, 31 (18) :2270-2282
[8]   The transcription factor Sox2 is required for osteoblast self-renewal [J].
Basu-Roy, U. ;
Ambrosetti, D. ;
Favaro, R. ;
Nicolis, S. K. ;
Mansukhani, A. ;
Basilico, C. .
CELL DEATH AND DIFFERENTIATION, 2010, 17 (08) :1345-1353
[9]   Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma [J].
Bettegowda, Chetan ;
Agrawal, Nishant ;
Jiao, Yuchen ;
Sausen, Mark ;
Wood, Laura D. ;
Hruban, Ralph H. ;
Rodriguez, Fausto J. ;
Cahill, Daniel P. ;
McLendon, Roger ;
Riggins, Gregory ;
Velculescu, Victor E. ;
Oba-Shinjo, Sueli Mieko ;
Marie, Suely Kazue Nagahashi ;
Vogelstein, Bert ;
Bigner, Darell ;
Yan, Hai ;
Papadopoulos, Nickolas ;
Kinzler, Kenneth W. .
SCIENCE, 2011, 333 (6048) :1453-1455
[10]   The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas [J].
Binda, Elena ;
Visioli, Alberto ;
Giani, Fabrizio ;
Lamorte, Giuseppe ;
Copetti, Massimiliano ;
Pitter, Ken L. ;
Huse, Jason T. ;
Cajola, Laura ;
Zanetti, Nadia ;
DiMeco, Francesco ;
De Filippis, Lidia ;
Mangiola, Annunziato ;
Maira, Giulio ;
Anile, Carmelo ;
De Bonis, Pasquale ;
Reynolds, Brent A. ;
Pasquale, Elena B. ;
Vescovi, Angelo L. .
CANCER CELL, 2012, 22 (06) :765-780